Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
39 /100
MEDIUM RISK
Score updated Aug 28, 2026

IMMX — Immix Biopharma, Inc. Dilution Risk Tracker

Track IMMX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IMMX — Get alerts when the score changes →

As of August 28, 2026, Immix Biopharma, Inc. (IMMX) has a DilutionWatch DilutionScore of 39/100, rated MEDIUM dilution risk. Immix Biopharma, Inc. has a market capitalization of $640.71M, 71.54M shares outstanding, 77 institutional holders tracked. Stored dilution-related fields include 31.5K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
50
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for IMMX.
🔔 Track IMMX — Get forecast alerts →

Market Data

Market Cap$640.71M
Shares Outstanding71.54M
Float40.34M
Cash$232.11M
Debt$1.04M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 34.2% shares (2026Q1 vs prior)
77 institutional holders · 34.24M shares
#1 JANUS HENDERSON GROUP PLC 9.60M shares
#2 Saturn V Capital Management LP 3.69M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 3.58M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest9.49M
Days to Cover5.2
% of Float23.5%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-31
xbrl XBRL CONVERTIBLE 2021-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual IMMX Dilution Snapshot

Immix Biopharma, Inc. (IMMX) has a DilutionScore of 39/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track IMMX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IMMX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for IMMX
IMMX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.